These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38223970)

  • 1. [Diagnostic modalities of a Behçet uveitis].
    Boca T; Rigo S
    Rev Med Liege; 2024 Jan; 79(1):48-53. PubMed ID: 38223970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [OCULAR MANIFESTATIONS IN BEHÇET DISEASE].
    Sar S; Tomkins-Netzer O
    Harefuah; 2022 Oct; 161(10):633-636. PubMed ID: 36315211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review for Diagnostics of the Year: Multimodal Imaging in Behçet Uveitis.
    Tugal-Tutkun I; Ozdal PC; Oray M; Onal S
    Ocul Immunol Inflamm; 2017 Feb; 25(1):7-19. PubMed ID: 27541278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuro-Behcet Disease and Ocular Inflammation: A Case Report and Literature Review.
    Patel SA; Okeagu C; Jones K; Chaudhry A; Berkenstock MK
    Ocul Immunol Inflamm; 2022 Jan; 30(1):95-103. PubMed ID: 32812810
    [No Abstract]   [Full Text] [Related]  

  • 5. Childhood-onset uveitis in Behçet disease:a descriptive study of 36 cases.
    Tugal-Tutkun I; Urgancioglu M
    Am J Ophthalmol; 2003 Dec; 136(6):1114-9. PubMed ID: 14644223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ocular manifestation of Behçet disease (study of 50 patients consulting in dermatology department)].
    Janati K; EL Omari K; Benchiki H; Hamdani M; Lakhdar H
    Rev Med Interne; 2005 Oct; 26(10):771-6. PubMed ID: 16169129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ocular manifestations in Behçet's disease].
    Zeghidi H; Saadoun D; Bodaghi B
    Rev Med Interne; 2014 Feb; 35(2):97-102. PubMed ID: 24290834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose interferon alfa-2a therapy in severe uveitis associated with Behçet disease.
    Onal S; Kazokoglu H; Direskeneli H; Yavuz S
    Am J Ophthalmol; 2009 Jun; 147(6):1109-10; author reply 1110. PubMed ID: 19463552
    [No Abstract]   [Full Text] [Related]  

  • 9. Anakinra for resistant Behçet uveitis: why not?
    Emmi G; Silvestri E; Cameli AM; Bacherini D; Vannozzi L; Squatrito D; Emmi L
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):152-3. PubMed ID: 24064028
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.
    Park JY; Chung YR; Lee K; Song JH; Lee ES
    Yonsei Med J; 2015 Jul; 56(4):1158-62. PubMed ID: 26069144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of uveitis in Behçet's disease in a referral center in Tunisia, North Africa.
    Khairallah M; Attia S; Yahia SB; Jenzeri S; Ghrissi R; Jelliti B; Zaouali S; Messaoud R
    Int Ophthalmol; 2009 Jun; 29(3):135-41. PubMed ID: 18365145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uveitis in Behçet disease in a tertiary center over 25 years: the KKESH Uveitis Survey Study Group.
    Arevalo JF; Lasave AF; Al Jindan MY; Al Sabaani NA; Al-Mahmood AM; Al-Zahrani YA; Al Dhibi HA; ;
    Am J Ophthalmol; 2015 Jan; 159(1):177-84.e1-2. PubMed ID: 25448998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ocular manifestations in Behçet's disease].
    Desbois AC; Terrada C; Cacoub P; Bodaghi B; Saadoun D
    Rev Med Interne; 2018 Sep; 39(9):738-745. PubMed ID: 29625716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behçet's Uveitis: Current Diagnostic and Therapeutic Approach.
    Çakar Özdal P
    Turk J Ophthalmol; 2020 Jun; 50(3):169-182. PubMed ID: 32631005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uveitis associated with pediatric behçet disease in the american midwest.
    Kesen MR; Goldstein DA; Tessler HH
    Am J Ophthalmol; 2008 Dec; 146(6):819-27.e2. PubMed ID: 18672222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: multicentre retrospective study.
    Atienza-Mateo B; Calvo-Río V; Beltrán E; Martínez-Costa L; Valls-Pascual E; Hernández-Garfella M; Atanes A; Cordero-Coma M; Miquel Nolla J; Carrasco-Cubero C; Loricera J; González-Vela MC; Vegas-Revenga N; Fernández-Díaz C; Demetrio-Pablo R; Domínguez-Casas LC; Luis Martín-Varillas J; Palmou-Fontana N; Hernández JL; González-Gay MÁ; Blanco R
    Rheumatology (Oxford); 2018 May; 57(5):856-864. PubMed ID: 29471416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Uveitis in Behçet's Syndrome in Germany - Prognosis During Current Therapy].
    Stübiger N; Deuter C; Doycheva D
    Klin Monbl Augenheilkd; 2020 May; 237(5):591-598. PubMed ID: 32434242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular Manifestations and Visual Outcomes of Behçet's Uveitis in a Thai population.
    Pathanapitoon K; Kunavisarut P; Saravuttikul FA; Rothova A
    Ocul Immunol Inflamm; 2019; 27(1):2-6. PubMed ID: 29020486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease.
    Gueudry J; Wechsler B; Terrada C; Gendron G; Cassoux N; Fardeau C; Lehoang P; Piette JC; Bodaghi B
    Am J Ophthalmol; 2008 Dec; 146(6):837-44.e1. PubMed ID: 19027420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of behçet uveitis.
    Tugal-Tutkun I; Gupta V; Cunningham ET
    Ocul Immunol Inflamm; 2013 Oct; 21(5):337-50. PubMed ID: 23730816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.